HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Reticulohistiocytosis — Clinical Guidelines

Overview

Multicentric reticulohistiocytosis (MRH) is a rare, multisystemic non-Langerhans cell histiocytosis primarily affecting the skin and joints, with potential involvement of other organs 1. It can mimic other arthritides like rheumatoid arthritis and gout, complicating diagnosis 2.

Diagnosis

Clinical Presentation: Characterized by cutaneous nodules and polyarthritis, often with symmetrical joint involvement 1 6.

Biopsy: Essential for diagnosis; skin or synovial biopsies reveal histiocytic multinucleated giant cells 1 3.

Imaging: Roentgenographic changes include sharply circumscribed, symmetric erosions predominantly in interphalangeal joints and early atlantoaxial involvement 6.

Laboratory Findings: No specific laboratory markers; differential diagnosis includes Sjögren's syndrome 1.

Management

First-Line Treatments: No consensus; often includes corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs) 1.

Adjunctive Treatments: Immunosuppressive agents like methotrexate or biologics may be considered based on severity 1.

Cytokine Inhibition: In cases with significant cytokine overproduction, targeting IL-1beta, IL-6, or TNF-alpha might be beneficial 3.

Special Populations

Comorbidities: MRH can present alongside conditions like Sjögren's syndrome and may be associated with paraneoplastic processes 1 2.

Oral Involvement: Recognizing oral manifestations is crucial for comprehensive diagnosis 4.

Key Recommendations

Biopsy Confirmation: Essential for definitive diagnosis of MRH (Evidence: Strong 1 3).

Early Imaging: Roentgenographic evaluation can aid in early diagnosis due to characteristic joint erosions (Evidence: Moderate 6).

Individualized Treatment: Treatment should be tailored based on disease severity and patient response, often starting with corticosteroids and considering immunosuppressive agents (Evidence: Expert opinion 1).

References

1 Toz B, Büyükbabani N, İnanç M. Multicentric reticulohistiocytosis: Rheumatology perspective. Best practice & research. Clinical rheumatology 2016. link 2 Horvath JR, Hoffman GS. Multicentric reticulohistiocytosis: a mimic of gout and rheumatoid arthritis. Cleveland Clinic journal of medicine 1999. link 3 Nakamura H, Yoshino S, Shiga H, Tanaka H, Katsumata S. A case of spontaneous femoral neck fracture associated with multicentric reticulohistiocytosis: oversecretion of interleukin-1beta, interleukin-6, and tumor necrosis factor alpha by affected synovial cells. Arthritis and rheumatism 1997. link 4 Katz RW, Anderson KF. Multicentric reticulohistiocytosis. Oral surgery, oral medicine, and oral pathology 1988. link90017-5) 5 Jessop S, Gordon W. Multicentric reticulohistiocytosis. A case report. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1975. link 6 Gold RH, Metzger AL, Mirra JM, Weinberger HJ, Killebrew K. Multicentric reticulohistiocytosis (lipoid dermato-arthritis). An erosive polyarthritis with distinctive clinical, roentgenographic and pathologic features. The American journal of roentgenology, radium therapy, and nuclear medicine 1975. link

Reticulohistiocytosis